Apellis Pharmaceuticals, Inc. — Director's Dealing 2019

Mar 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2019-03-11

Reporting Person: Morningside Venture Investments Ltd (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-11	Common Stock	P	441176	$17.00	Acquired	12015802	Direct

Footnotes

F1: Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.